MedPath

rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke

Not Applicable
Terminated
Conditions
Stroke
Interventions
Device: High Frequency rTMS
Device: Sham rTMS
Registration Number
NCT03441334
Lead Sponsor
Texas Woman's University
Brief Summary

The study will enroll 5 individuals post-stroke to examine the feasibility and efficacy of a high frequency repetitive transcranial magnetic stimulation (rTMS) combined with body weight supported treadmill training.

Detailed Description

The purpose of this pilot study is to examine the feasibility and efficacy of 5Hz repetitive transcranial magnetic stimulation (rTMS) applied to bilateral motor areas as an adjuvant intervention to task-specific body weight supported treadmill training (BWSTT) in individuals with subacute stroke.

Five individuals with a diagnosis of subacute stroke will be recruited and assigned to either high frequency or sham rTMS group.Both groups will receive a comprehensive assessment of their motor function, gait performance and neurophysiological function before the training. Both groups will then go through a 10 week (24 sessions) of gait training with body weight supported treadmill. For the high frequency rTMS group, they will receive 5 Hz rTMS applied to bilateral motor areas prior to each gait training session. For the sham rTMS group, they will receive a sham stimulation prior to the gait training sessions. All participants will receive another comprehensive assessment after the training concludes. The assessor will be blinded to the intervention.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  1. 18-80 years old
  2. < 2 months post stroke at the time of enrollment
  3. first time stroke:
  4. able to walk > 25 feet with or without assistive device and with no more than moderate assistance:
  5. able to follow 1-step commands
  6. able to communicate verbally
Read More
Exclusion Criteria
  1. severe medical problems (e.g. recent cardiac infarct, heart failure, cancer)
  2. presence of conditions that could affect gait training (e.g. amputation, severe arthritis)
  3. bilateral stroke
  4. non-ambulatory prior to stroke
  5. BMI > 40
  6. any contraindications to TMS (e.g. history of seizure, cardiac pacemaker, metal or magnetic implants)
  7. pregnant or potentially to be pregnant
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High Frequency rTMSHigh Frequency rTMSThe High Frequency rTMS group will receive real repetitive transcranial magnetic stimulation (rTMS) in 5Hz at 90% of resting motor threshold delivered to the bilateral motor areas via a figure of 8 air-filmed coil. The stimulation is structured as 24 10-second trains with a inter-train interval of 30 second.
Sham rTMSSham rTMSThe Sham rTMS group will receive the same protocol but delivered via a sham coil which generates the same auditory and cutaneous feedback as the real stimulation. However, there will be no active stimulation.
Primary Outcome Measures
NameTimeMethod
Change in Walking Speed10 weeks

Participant's regular and fast walking speeds (in m/s) will be measured using GaitRite. A faster walking speed indicates a better gait performance.

Secondary Outcome Measures
NameTimeMethod
Change in Cortical Excitability10 weeks

Cortical excitability will be measured using single pulse transcranial magnetic stimulation. Excitability will be quantified using motor evoked potential amplitude (in mV). A higher motor evoked potential amplitude indicates a greater level of excitability.

Change in Quality of Life10 weeks

Quality of life will be measure using Stroke Impact Scale (SIS). The SIS is a paper and pencil questionnaire consisting 59 items grouped into 8 domains. Each item is rated on a 5-point Likert scale; a higher item score indicates a lower level of difficulty experienced with the item. Item scores are averaged and transformed into domain scores ranging from 0 to 100. A higher domain score indicates a lower level of difficulty. The SIS is well-validated in stroke.

Change in Motor Function10 weeks

Motor function will be quantified using Fugl-Meyer Motor Assessment. The Fugl-Meyer Assessment is well-validated in stroke and has a total score ranging from 0 to 100. A higher total score suggests a better level of motor function.

Change in Walking Endurance10 weeks

Walking endurance will be measured using Six Minute Walk Test and measured in meters. A higher score in the 6 minute walk test (in meters) indicates a better walking endurance.

Trial Locations

Locations (1)

Texas Woman's University

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath